Sei Investments Co. lifted its holdings in Rxo Inc (NYSE:RXO - Free Report) by 71.7% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 133,339 shares of the company's stock after acquiring an additional 55,680 shares during the period. Sei Investments Co. owned approximately 0.08% of RXO worth $1,949,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. First Trust Advisors LP bought a new stake in shares of RXO during the 1st quarter valued at about $797,000. PNC Financial Services Group Inc. increased its holdings in RXO by 47.3% in the first quarter. PNC Financial Services Group Inc. now owns 6,287 shares of the company's stock worth $92,000 after purchasing an additional 2,019 shares in the last quarter. Cassaday & Co Wealth Management LLC acquired a new position in RXO in the first quarter valued at approximately $29,000. Dimensional Fund Advisors LP boosted its holdings in shares of RXO by 32.7% during the 1st quarter. Dimensional Fund Advisors LP now owns 2,048,903 shares of the company's stock worth $29,949,000 after buying an additional 504,955 shares in the last quarter. Finally, Illinois Municipal Retirement Fund bought a new position in shares of RXO during the 1st quarter worth approximately $1,537,000. 92.73% of the stock is owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
Several analysts have recently commented on RXO shares. William Blair set a $30.00 price objective on shares of RXO in a research report on Friday. Susquehanna boosted their target price on shares of RXO from $18.00 to $20.00 and gave the company a "negative" rating in a research report on Tuesday, July 14th. Stephens raised shares of RXO to a "hold" rating in a research note on Wednesday, July 8th. Citigroup upgraded shares of RXO from a "market perform" rating to an "outperform" rating in a report on Friday. Finally, Wells Fargo & Company lifted their price target on shares of RXO from $15.00 to $22.00 and gave the company an "equal weight" rating in a research note on Friday, May 8th. Five equities research analysts have rated the stock with a Buy rating, ten have issued a Hold rating and four have given a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus price target of $23.85.
Get Our Latest Stock Report on RXO
RXO Stock Performance
RXO opened at $21.79 on Monday. The company has a current ratio of 1.27, a quick ratio of 1.27 and a debt-to-equity ratio of 0.30. The company's fifty day moving average price is $26.10 and its two-hundred day moving average price is $20.13. Rxo Inc has a 1-year low of $10.43 and a 1-year high of $29.90. The company has a market cap of $3.59 billion, a price-to-earnings ratio of -35.72 and a beta of 2.10.
RXO (NYSE:RXO - Get Free Report) last released its quarterly earnings data on Thursday, August 6th. The company reported $0.06 earnings per share for the quarter, beating analysts' consensus estimates of $0.04 by $0.02. The firm had revenue of $1.77 billion for the quarter, compared to analyst estimates of $1.63 billion. RXO had a negative net margin of 1.72% and a negative return on equity of 0.98%. The business's quarterly revenue was up 25.0% compared to the same quarter last year. During the same period last year, the firm earned $0.04 earnings per share. On average, analysts expect that Rxo Inc will post 0.09 EPS for the current fiscal year.
RXO News Summary
Here are the key news stories impacting RXO this week:
- Positive Sentiment: RXO highlighted market-share gains and profitable volume growth, including a 2% increase in truckload brokerage volume and a record sequential improvement in gross profit per load. Market Share Gains and Improved Profitability Drive Strong Second-Quarter Results for RXO
- Positive Sentiment: The earnings and revenue beats, along with stronger-than-expected operating metrics, helped drive investor enthusiasm and a positive premarket reaction. RXO Q2 Earnings and Revenues Surpass Estimates
- Positive Sentiment: Citizens JMP upgraded RXO from “market perform” to “outperform” and set a $30 price target, while Truist maintained a “buy” rating with a $28 target, both implying meaningful potential upside. Analyst Ratings
- Neutral Sentiment: Citi lowered its price target from $30 to $23 and shifted to a “neutral” rating, reflecting more cautious expectations despite the quarterly beat. Citi Analyst Action
- Negative Sentiment: Some analysis argues that RXO’s strong revenue growth was driven largely by higher freight rates and fuel prices, while gross profit declined and adjusted EBITDA remained flat. Rising working-capital requirements and leverage also raise concerns about the quality and durability of the recovery. RXO Still Unable To Capture Upcycle Economics
About RXO
(
Free Report)
RXO Inc NYSE: RXO is a leading asset-light provider of digital freight brokerage and managed transportation solutions. The company leverages a proprietary technology platform to connect shippers with a network of third-party carriers, enabling optimized route planning, real-time shipment tracking, and dynamic pricing. RXO’s end-to-end service model spans full truckload, less-than-truckload (LTL), intermodal and cross-border freight movements, designed to improve efficiency and reduce transportation costs for its customers.
Operating primarily across North America, RXO serves a diverse base of shippers in industries ranging from retail and consumer goods to manufacturing and automotive.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider RXO, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and RXO wasn't on the list.
While RXO currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.